Serono's reproductive health business
GPTKB entity
Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
business
|
| gptkbp:acquisition |
Merck KGaA
|
| gptkbp:aimsTo |
improve reproductive health outcomes
|
| gptkbp:collaboratesWith |
healthcare_providers
|
| gptkbp:conducts |
clinical trials
|
| gptkbp:develops |
hormonal therapies
|
| gptkbp:employs |
researchers
scientists |
| gptkbp:focusesOn |
reproductive health
|
| gptkbp:hasCompetitors |
gptkb:Ferring_Pharmaceuticals
gptkb:Bayer_AG gptkb:Irvine_Scientific gptkb:Eli_Lilly_and_Company gptkb:CooperSurgical |
| gptkbp:hasImpactOn |
family planning
|
| gptkbp:hasMission |
enhance reproductive health access
|
| gptkbp:hasParticipatedIn |
fertility_clinics
|
| gptkbp:hasPartnershipsWith |
non-profit organizations
|
| gptkbp:hasProductLine |
gptkb:Menopur
gptkb:Cetrotide gptkb:Luveris Gonal-f Ovitrelle |
| gptkbp:hasResearchFocus |
endocrinology
embryology gynecology andrology |
| gptkbp:headquarteredIn |
gptkb:Geneva,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Serono's reproductive health business
|
| gptkbp:isDedicatedTo |
advancing reproductive science
|
| gptkbp:isEngagedIn |
community outreach
|
| gptkbp:isFocusedOn |
patient-centered care
|
| gptkbp:isInfluencedBy |
regulatory changes
|
| gptkbp:isInvolvedIn |
patient education
policy advocacy sustainability initiatives |
| gptkbp:isKnownFor |
innovation in fertility treatments
|
| gptkbp:isPartOf |
biotechnology industry
Merck KGaA |
| gptkbp:isRecognizedFor |
quality of products
|
| gptkbp:isRegulatedBy |
health authorities
|
| gptkbp:isSupportedBy |
clinical guidelines
scientific research |
| gptkbp:offers |
fertility treatments
|
| gptkbp:offersServices |
counseling services
|
| gptkbp:operatesIn |
global markets
|
| gptkbp:partnerships |
academic institutions
|
| gptkbp:provides |
assisted reproductive technology
|
| gptkbp:providesSupportFor |
patients undergoing treatment
|
| gptkbp:targets |
infertility patients
|
| gptkbp:wasFoundedIn |
2000
|